# Myeloid Derived Suppressor Cells in Systemic Lupus Erythematosus

> **NCT05424627** · — · NOT_YET_RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 80 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05424627
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-07-15
- **Primary completion:** 2026-07-15
- **Final completion:** 2027-01-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05424627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05424627, "Myeloid Derived Suppressor Cells in Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05424627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*